Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis - PubMed (original) (raw)

Clinical Trial

. 1995 Oct;38(10):1466-74.

doi: 10.1002/art.1780381013.

Affiliations

• PMID: 7575696
• DOI: 10.1002/art.1780381013

Clinical Trial

Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis

A van der Heide et al. Arthritis Rheum. 1995 Oct.

Abstract

Objective: To investigate the extent to which early radiologic damage is predicted by joint inflammation in patients with newly diagnosed rheumatoid arthritis (RA).

Methods: Regression analysis was performed on 1-year progression of total radiologic damage for baseline characteristics and cumulative disease activity measures, and the effects of continued joint inflammation on the progression of damage in separate joint groups were investigated.

Results: Odds ratios for progression of total damage were 12 for the presence of rheumatoid factor, 5 for the presence of damage at baseline, and 2 for cumulative joint inflammation. A positive association between continued joint inflammation and progression of damage was found to be statistically significant for most joint groups.

Conclusion: Progression of radiologic damage in patients with newly diagnosed RA is independently associated with the presence of rheumatoid factor and damage at baseline and with cumulative joint inflammation.

PubMed Disclaimer

Similar articles

• Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.
  Garnero P, Landewé R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, Van Der Heijde D, Boonen A, Geusens P. Garnero P, et al. Arthritis Rheum. 2002 Nov;46(11):2847-56. doi: 10.1002/art.10616. Arthritis Rheum. 2002. PMID: 12428224 Clinical Trial.
• Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
  Ørnbjerg LM, Østergaard M, Bøyesen P, Krogh NS, Thormann A, Tarp U, Poulsen UE, Espesen J, Schlemmer A, Graudal N, Kollerup G, Jensen DV, Madsen OR, Glintborg B, Christensen T, Lindegaard H, Bøhme W, Hansen A, Andersen AR, Hetland ML. Ørnbjerg LM, et al. J Rheumatol. 2014 Dec;41(12):2352-60. doi: 10.3899/jrheum.131299. Epub 2014 Oct 1. J Rheumatol. 2014. PMID: 25274894
• Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis.
  Plant MJ, Williams AL, O'Sullivan MM, Lewis PA, Coles EC, Jessop JD. Plant MJ, et al. Arthritis Rheum. 2000 Jul;43(7):1473-7. doi: 10.1002/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N. Arthritis Rheum. 2000. PMID: 10902748 Clinical Trial.
• Structural joint damage and hand bone loss in patients with rheumatoid arthritis.
  Ørnbjerg LM. Ørnbjerg LM. Dan Med J. 2018 Mar;65(3):B5452. Dan Med J. 2018. PMID: 29510810 Review.
• Effects of cyclosporin on joint damage in rheumatoid arthritis. The Italian Rheumatologists Study Group on Rheumatoid Arthritis.
  Ferraccioli GF, Bambara LM, Ferraris M, Perpignano G, Cattaneo R, Porzio F, Accardo S, Mattara L, Zoppini A, Benucci M, Ostuni PA, Pasero G. Ferraccioli GF, et al. Clin Exp Rheumatol. 1997 May-Jun;15 Suppl 17:S83-9. Clin Exp Rheumatol. 1997. PMID: 9266138 Review.

Cited by

• MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.
  Boeters DM, Nieuwenhuis WP, Verheul MK, Newsum EC, Reijnierse M, Toes RE, Trouw LA, van der Helm-van Mil AH. Boeters DM, et al. Arthritis Res Ther. 2016 Aug 2;18:179. doi: 10.1186/s13075-016-1076-0. Arthritis Res Ther. 2016. PMID: 27485323 Free PMC article.
• Value of self-performed joint counts in rheumatoid arthritis patients near remission.
  Radner H, Grisar J, Smolen JS, Stamm T, Aletaha D. Radner H, et al. Arthritis Res Ther. 2012 Mar 14;14(2):R61. doi: 10.1186/ar3777. Arthritis Res Ther. 2012. PMID: 22417647 Free PMC article. Clinical Trial.
• Evidence for treating rheumatoid arthritis to target: results of a systematic literature search.
  Schoels M, Knevel R, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas DT, Burmester G, Combe B, Cutolo M, Dougados M, Emery P, van der Heijde D, Huizinga TWJ, Kalden J, Keystone EC, Kvien TK, Martin-Mola E, Montecucco C, de Wit M, Smolen JS. Schoels M, et al. Ann Rheum Dis. 2010 Apr;69(4):638-643. doi: 10.1136/ard.2009.123976. Ann Rheum Dis. 2010. PMID: 20237123 Free PMC article. Review.
• The comparison of ultrasonographic and scintigraphic findings of early arthritis in revealing rheumatoid arthritis according to criteria of American College of Rheumatology.
  Ozgul A, Yasar E, Arslan N, Balaban B, Taskaynatan MA, Tezel K, Baklaci K, Ozgüven MA, Kalyon TA. Ozgul A, et al. Rheumatol Int. 2009 May;29(7):765-8. doi: 10.1007/s00296-008-0765-7. Epub 2008 Nov 27. Rheumatol Int. 2009. PMID: 19037610
• Predicting factors for severity of rheumatoid arthritis: a prospective multicenter cohort study of 172 patients over 3 years.
  Wagner E, Ammer K, Kolarz G, Krajnc I, Palkonyai E, Scherak O, Schödl C, Singer F, Temesvari P, Wottawa A. Wagner E, et al. Rheumatol Int. 2007 Sep;27(11):1041-8. doi: 10.1007/s00296-007-0343-4. Epub 2007 Apr 11. Rheumatol Int. 2007. PMID: 17429638

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Medical

  • MedlinePlus Health Information